Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2825 of 2873 entries
View as:

Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion

Phase: N/A Priority: Normal
NCT ID: NCT05036083 Org: User:
Start: 03/19/21 End: 03/25/24 Due: 03/25/25

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT04373720 Org: User:
Start: 03/20/20 End: 12/31/26 Due: 12/31/27

Multimodal Treatment Strategy for Cancer Cachexia

Phase: N/A Priority: Normal
NCT ID: NCT00625742 Org: User:
Start: 02/29/08 End: 06/30/14 Due: 06/30/15

Literacy and Smoking Risk Communications

Phase: N/A Priority: Normal
NCT ID: NCT00684437 Org: User:
Start: 05/21/08 End: 05/31/26 Due: 05/31/27

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01949662 Org: User:
Start: 01/31/14 End: 01/01/26 Due: 01/01/27

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06959511 Org: User:
Start: 07/01/25 End: 10/01/29 Due: 10/01/30

Resting-State Functional MRI in Glioma Patients Before and After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03964909 Org: User:
Start: 04/24/17 End: 11/12/24 Due: 11/12/25

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Phase: N/A Priority: Normal
NCT ID: NCT00980239 Org: User:
Start: 09/30/09 End: 08/31/15 Due: 08/31/16

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01827111 Org: User:
Start: 04/25/13 End: 09/21/20 Due: 09/21/21

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05065047 Org: User:
Start: 01/05/23 End: 05/01/27 Due: 05/01/28

Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04975919 Org: User:
Start: 09/29/21 End: 05/31/26 Due: 05/31/27

Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid Prescriptions

Phase: N/A Priority: Normal
NCT ID: NCT03989128 Org: User:
Start: 04/23/19 End: 01/01/21 Due: 01/01/22

Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04029038 Org: User:
Start: 05/15/19 End: 11/16/22 Due: 11/16/23

Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00038246 Org: User:
Start: 10/31/00 End: 12/31/04 Due: 12/31/05

Respiratory Syncytial Virus - RSV Protocol

Phase: N/A Priority: Normal
NCT ID: NCT01502072 Org: User:
Start: 12/28/11 End: 02/01/20 Due: 02/01/21

Rituximab and ABVD for Hodgkin's Patients

Phase: N/A Priority: Normal
NCT ID: NCT00504504 Org: User:
Start: 03/31/01 End: 03/31/12 Due: 03/31/13

Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients

Phase: N/A Priority: Normal
NCT ID: NCT03048266 Org: User:
Start: 11/05/15 End: 11/01/26 Due: 11/01/27

Chemoradiation-Induced Nausea and Emesis: Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT00394602 Org: User:
Start: 04/07/04 End: 05/08/19 Due: 05/08/20

Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)

Phase: N/A Priority: Normal
NCT ID: NCT02044601 Org: User:
Start: 06/30/14 End: - Due: -

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00016367 Org: User:
Start: 05/13/99 End: 12/14/04 Due: 12/14/05

Sexual Functioning in Cervical Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00522223 Org: User:
Start: 09/10/02 End: 06/08/18 Due: 06/08/19

Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System

Phase: N/A Priority: Normal
NCT ID: NCT01596127 Org: User:
Start: 01/24/13 End: 03/23/17 Due: 03/23/18

Radiation Therapy and Cardiac Enzymes

Phase: N/A Priority: Normal
NCT ID: NCT00777751 Org: User:
Start: 10/06/08 End: 11/21/16 Due: 11/21/17

Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00409331 Org: User:
Start: 12/31/06 End: 01/31/09 Due: 01/31/10

Ph II Study of Azacitidine in Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00569660 Org: User:
Start: 06/30/05 End: 04/30/08 Due: 04/30/09